Divis Laboratories reports 18% rise in Q3 net profit

04 Feb 2013 Evaluate

Divis Laboratories has reported results for third quarter ended December 31, 2012.

The company has registered a rise of 17.70% in its net profit at Rs 144.24 crore in Q3FY13 as compared to Rs 122.55 crore in the corresponding quarter previous year. The total income of the company has increased by 25.68% to Rs 556.68 crore for the quarter under review as compared to Rs 442.94 crore in the same quarter last year.

Divis Laboratories, together with its subsidiaries, engaged in the manufacture and sale of active pharma ingredients (APIs) and intermediates for the pharmaceutical industry in India and worldwide.

Divis Lab Share Price

6473.35 2.75 (0.04%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×